Danaher Corp.

DHR ·Technology, Scientific & Technical Instruments, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Revenue $19.89B $18.33B $16.88B $14.43B $12.87B $18.28B $18.26B $16.09B
Biotechnology $0 $0 $0
Life Sciences $6.47B $5.71B $5.38B
Diagnostics $6.25B $5.84B $5.12B
Dental $2.84B $2.81B $2.78B
Environmental & Applied Solutions $4.33B $3.97B $3.60B
Cost of Revenue $7.54B $6.95B $7.55B $6.66B $6.02B $8.94B $8.85B $7.91B
Gross Profit $9.51B $8.57B $9.33B $7.77B $6.85B $9.34B $9.41B $8.18B
Gross Margin 47.8% 46.8% 55.3% 53.8% 53.2% 51.1% 51.6% 50.8%
Operating Expenses
Research & Development $1.06B $956.4M $975.1M $861.4M $769.4M $1.10B $1.14B $1.02B
SG&A Expense $5.39B $5.04B $5.62B $4.75B $4.04B $5.12B $5.18B $4.61B
Operating Income $3.06B $2.57B $2.74B $2.16B $2.05B $3.12B $3.17B $2.62B
Operating Margin 15.4% 14.0% 16.2% 15.0% 15.9% 17.1% 17.3% 16.3%
Interest Expense $137.0M $140.1M $184.4M $139.8M $94.7M $141.2M $157.5M $141.6M
Pretax Income $2.96B $2.54B $2.61B $2.04B $2.09B $3.42B $3.01B $2.45B
Income Tax Expense $556.0M $371.0M $457.9M $292.7M $447.5M $825.7M $711.5M $512.5M
Net Income $2.65B $2.49B $2.55B $3.36B $2.60B $2.70B $2.39B $2.17B
Net Margin 13.3% 13.6% 15.1% 23.3% 20.2% 14.7% 13.1% 13.5%
EPS (Basic) $3.78 $3.58 $3.69 $4.81 $3.70 $3.87 $3.45 $3.21
EPS (Diluted) $3.74 $3.53 $3.65 $4.74 $3.63 $3.80 $3.36 $3.11
Shares Outstanding (Basic) 700.6M 695.8M 691.2M 698.1M 702.2M 696.0M 693.4M 676.2M
Shares Outstanding (Diluted) 710.2M 706.1M 699.8M 708.5M 716.1M 711.0M 713.1M 701.2M
Dividends Per Share
← Newer Page 2 of 3 Older →